The Science Supporting Our Approach Our protocols are directly informed by the latest clinical research, including the groundbreaking 2025 Galderma study that specifically examined facial volume loss in patients using GLP-1 medications
Bristol Myers Squibb Bristol Myers Squibb engages in exploring innovative peptide therapeutics and combination treatments
At TrimRx, we leverage the clinically proven benefits of medications like Compounded Semaglutide, Oral Semaglutide, Ozempic, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro, Zepbound, and Wegovy
For a 250-pound person, that would mean losing around 72 pounds in about 16 months
Evidence-Based Glow From Within High-quality glutathione brands rely on clinically studied forms (L-Glutathione, S-Acetyl, Free Form) that support antioxidant activity and natural melanin balance